What is the stock price trajectory of IQVIA Holdings Inc. (IQV)?

IQVIA Holdings Inc. [IQV] stock is trading at $181.61, up down -2.20%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The IQV shares have lost -4.73% over the last week, with a monthly amount drifted -15.92%, and not seem to be holding up well over a long-time horizon.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored

On 28, September 2022, IQVIA Decentralized Clinical Trial Program Achieves Independent GDPR Validation. In a post published today on Yahoo Finance, IQVIA becomes first DCT program to demonstrate commitment to data protection in Europe.

From an analyst’s perspective:

IQVIA Holdings Inc. [NYSE: IQV] stock has seen the most recent analyst activity on August 25, 2022, when Credit Suisse initiated its Outperform rating and assigned the stock a price target of $300. Previously, SVB Leerink started tracking the stock with Outperform rating on July 15, 2022, and set its price target to $256. On May 24, 2022, Guggenheim initiated with a Buy rating and assigned a price target of $244 on the stock. Piper Sandler upgraded its rating to a Overweight and increased its price target to $255 on April 29, 2022. Wells Fargo downgraded its rating to a Equal Weight but $235 remained the price target by the analyst firm on April 25, 2022. In a note dated April 16, 2021, Stephens upgraded an Overweight rating on this stock and boosted its target price from $180 to $250.

IQVIA Holdings Inc. [IQV] stock has fluctuated between $182.03 and $285.61 over the past year. Currently, Wall Street analysts expect the stock to reach $267.41 within the next 12 months. IQVIA Holdings Inc. [NYSE: IQV] shares were valued at $181.61 at the most recent close of the market. An investor can expect a potential return of 47.24% based on the average price forecast.

Analyzing the IQV fundamentals

IQVIA Holdings Inc. [NYSE:IQV] reported sales of 3.55 billion for the most recent quarter, which represents a growth of 3.00%. Gross Margin for this corporation currently stands at +24.37% with Operating Margin at +10.22%, Pretax Margin comes in at +8.13%, and Net Margin reading is +6.96%.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 179.90 points at the first support level, and at 178.19 for the second support level. However, for the 1st resistance point, the stock is sitting at 183.58, and for the 2nd resistance point, it is at 185.55.

IQVIA Holdings Inc. [IQV] reported earnings per share of $2.44 for its fiscal quarter that ended on 6/29/2022. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $2.38/share, meaning a difference of $0.06 and a surprise factor of 2.50%. By comparison, the stated earnings for the previous quarter ended on 3/30/2022 were $2.47 per share as compared to estimates of $2.42 per share, a difference of $0.05 representing a surprise of 2.10%.

Ratios To Look Out For

For context, IQVIA Holdings Inc.’s Current Ratio is 1.00. In addition, the Quick Ratio stands at 0.91 and the Cash Ratio stands at 0.28. Considering the valuation of this stock, the price to sales ratio is 3.96, the price to book ratio is 8.90 and the P/E (TTM) ratio is 30.33.

Transactions by insiders

In the past 3 months, 0 insiders have purchased 0 shares, and 1 have sold 2,588 shares. Recent insider trading involved DANHAKL JOHN G, Director, that happened on Dec 22 when 10000.0 shares were purchased. Director, CONNAUGHTON JOHN completed a deal on Nov 29 to sell 0.56 million shares. Meanwhile, Bruehlman Ronald E sold 4.0 shares on Oct 25.